ABSTRACT: In this article, the trajectories of S-deoxyephedrine (SBD) along molecular channels within the complex protein structure of third dopamine receptor (D 3 R) are analyzed via molecular dynamic techniques, including potential mean force calculations of umbrella samplings from the 4.5 version of the GROMACS program. Changes in free energy due to the movement of SBD within D 3 R are determined, and the molecular dynamic mechanisms of SBD transmitting along molecular channels are probed. Molecular simulated results show that the change in free energy is calculated as 171.7 kJ·mol −1 for the transmission of SBD toward the outside of the cell along the y+ axis functional molecular channel and is 275.0 kJ·mol −1 for movement toward the intracellular structure along the y− axis. Within the internal structure of D 3 R, the changes in free energy are determined to be 103.6, 242.1, 459.7, and 127.8 kJ·mol −1 for transmission of SBD along the x+, x−, z+, and z− axes, respectively, toward the cell bilayer membrane, which indicates that SBD leaves much more easily along the x+ axis through the gap between the TM5 (the fifth transmembrane helix) and TM6 (the sixth transmembrane helix) from the internal structure of D 3 R. The values of free-energy changes indicate that SBD molecules can clear the protective channel within D 3 R, which helps dopamine molecules to leave the D 3 R internal structure along the x+ axis and to prevent them for exerting excessive neurotransmitter function. Therefore, our results suggest that SBD is effective for development as a drug for treating schizophrenia and its pharmacology is closely related to its dynamics and mechanisms within the molecular pathway of dopamine receptors.
■ INTRODUCTION
Schizophrenia is a serious mental disease with a 0.5% incidence rate of the total population (in world) and is characterized by changes in basic personality, thinking, emotion, behavior, and disharmony between mental activity and the environment. 1 The disease does not only affect mental health but early death frequently occurs in diseased patients in 12−15 years compared with the average person. 2 Thus, schizophrenia results in more loss of lives than that caused by most cancers and physical illnesses. 2 Although the precise societal burden of schizophrenia is hardly known despite the wide diversity of accumulated data and employed methods, cost-of-illness data uniformly point to disquieting human and financial costs. 3 At present, there exist three hypotheses (theories) that physicochemically explain schizophrenia, namely, the dopaminergic hypothesis, glutamate hypothesis, and 5-hydroxy tryptamine hypothesis. 4 These three kinds of hypotheses ultimately lead to dopamine hyperfunction, in which dopamine molecules excessively overact with the neurotransmitter function. Therefore, all current clinical medical treatments for schizophrenia work by blocking dopamine molecules overly to play a neurotransmitter function. Dopamine (DA) is an important neurotransmitter in the brain that aids the regulation of motor functions, cognitive activity, drug addiction, and other physiological and pathological processes through the expression of dopamine receptors in the central nervous system. 4, 5 There are five subtypes of dopamine receptor membrane proteins in the central nervous system (CNS), all of which are G protein coupled receptors and composed of seven transmembrane (TM) domains (7-GM). Studies on dopamine receptors began in the late 1970s, when the existence of D1, D2, two classes of dopamine subtype receptors was first confirmed. 6 In the early 1990s, with the development of biological cloning technology, five subtypes of dopamine receptor molecules were cloned: D 2 R, D 3 R, and D 4 R belonging to the D2-like receptor group and D 1 R and D 5 R to the D1 group. 7−11 Considering the diversity of dopamine receptor subtypes, the specificity of their distribution within brain regions, and their functional differences in the synaptic environment, the DA system in the brain is highly complex. Treatments for schizophrenia and Parkinson's disease (PD) as well as those for drug addiction are all closely related to the complex DA system. 12−18 Many findings from studies on these mental diseases have been achieved that have paved the way for more in-depth studies. For example, Arvid Carlson, Paul Greengard, and Eric Kandel won the 2000 Nobel Prize in medicine after discovering that dopamine molecules act as a signal transduction and in the regulation of motor function, cognitive activity, drug addiction, and other physiological and pathological processes. 12 In 2010, the only crystal protein structure of the dopamine third receptor (D 3 R) was reported after problems with membrane protein stability and crystallization had been overcome. 19 In a previous study, we had obtained the D 3 R complex protein structure based on the crystal structure to furthermore study the interaction between D 3 R and dopamine and analyze how DA affects neurotransmitter function within the D 3 R spatial structure, which is considered to be surrounded by seven transmembrane helices. 20, 21 On the basis of this complex protein, we had studied the molecular dynamics of DA moving along several directions within D 3 R and obtained the trajectory of DA moving within D 3 R, as shown in Figure 1 . 22 In Figure 1 , the transmembrane helix region of the receptor protein can form a functional space but it also constitutes a molecular pathway for the transport of dopamine molecules to move within the seven transmembrane helices. Molecular channels are divided into two categories, namely: (1) a functional molecular channel for transferring molecules to play an important role of function as neurotransmitter; and (2) a protective molecular channel to prevent excess molecular function from molecular damage and to play a role in body mental protection. 4, 15, 22 Considering the role of these channels, it is reasonable to concur that all current pharmacological treatments for schizophrenia work by blocking dopamine receptors by means of blocking these functional molecular channels. 23 Furthermore, schizophrenia may also occur if the free energy needed by DA to move along a protective channel increases or as a result of a protective channel blocked by the receptor protein conformational variation. 22 Therefore, it is essential to maintain the smoothness of the DA protective channel to avoid dopamine hyperfunction or to prevent DA from excessive function as a neurotransmitter, which is a plausible new method for controlling and treating schizophrenia.
Because it is known that S-deoxyephedrine (SBD) acts on dopamine receptors in the CNS cells, it may also play a functional role by passing through the functional channel of a dopamine receptor or may prevent excessive molecular function by transmitting through the protective channel. In this article, we studied the trajectories and movement of SBD along the channels within D 3 R and changes in free energy along the trajectories to investigate the kinetics and mechanism of SBD and its CNS pharmacological effects within dopamine receptors. Our results show SBD to have a very unique character preferably moving through a protective channel unlike some molecules preferably moving through the functional channel. 24, 25 SBD moves along the functional molecular channel within D 3 R toward the outside of the cell, with a freeenergy change of 171.7 kJ·mol −1 , whereas movement toward intracellular orientation induces a free-energy change of 275 kJ· mol −1 . Furthermore, SBD trajectories along the protective molecular channels within D 3 R in the x+, x−, z+, and z− axes toward spaces in the cellular membrane result in free-energy changes of 103.6, 242.1, 459.7, and 127.8 kJ·mol −1 respectively. In this article, the results suggest that SBD is more likely to leave the internal structure of D 3 R between TM5 and TM6 along the protective channels.
■ RESULTS AND DISCUSSION
Research Systems of D 3 R with SBD. Like some molecules reported in our previous articles, 22, 24, 25 SBD is not a large molecule because large molecules are not accessible within dopamine molecular channels. In addition, SBD is a molecular state because the charged residues along the molecular channels have a very strong interaction with the ion state of molecules. If molecules are the ion states, they cannot move along the channels. On the basis of the D 3 R−DA complex protein structure, using dopamine as a pointer molecule, the SBD molecule is docked into D 3 R to form the SBD−D 3 R complex protein, which is performed for 20 ns of molecular dynamics simulation, whose results are shown in Figure 2 (right). Because the D 3 R protein structure originates from the crystal structural data, for modifying the crystal protein structure, 20 ns of MD simulation may be available. In 2011, 20 we had demonstrated that the 300 ns MD simulation of D 3 R protein structure is not better than it for 20 ns of MD simulation to modify the crystal protein structure of D 3 R by comparing the binding free energy between the dopamine molecule and D 3 R protein. Generally, it is known that the crystal protein structure without MD modification of simulation does have structural problems but if the MD simulation modification time is too long, it will create new problems; at the same time, it will make the protein structure lose a lot of important protein crystal data. Therefore, the basic characteristics of the binding free energy between SBD and D3R protein should be maintained for both the 20 ns simulated protein and the protein in the nature. SBD is a chiral molecule with S chiral configuration, whose molecular structure is also shown in Figure 2 . Figure 2 also shows that SBD and ETQ (eticlopride) have similar binding sites within D 3 R. In a previous study, we determined the active site residues via quantum chemical calculations. 20 In the D 3 R structure, the seven residues that act as active sites for SBD include Asp75, Asp110, Cys114, Trp342, Phe346, Gly372, and Tyr373. The remaining six residues except Asp75 are located about 6 Å around the ETQ molecule (Table  1) , whereas similar various amino acids act as the active sites for SBD and ETQ. However, the SBD molecule is located in the inner cavity of D 3 R. ETQ is an antischizophrenia drug whose active cavity is located within D 3 R, as shown in Figure 2 . 19 This target of the cavity also should be the active site of SBD for binding to D 3 R. Figure 3 displays the system structure, which contains a total of 23 484 atoms. In addition to D 3 R and SBD, there are 84 1-palmitoyl-2-oleoylsn-glycero-3-phosphatidylcholine (POPC) phospholipid molecules, 5438 water molecules, and 8 Cl The values of RMSD demonstrate that after 2.5 ns of MD simulation, the D 3 R−SBD system reached stable equilibrium with background values of ±0.01 nm located at 4.11 nm, ±0.01 nm located at 0.29 nm for D 3 R, and ±0.01 nm located at 0.14 nm for SBD. On the basis of the molecular dynamics simulation, these results show that the system achieved a balanced equilibrium and can be used as the initial structure to study the trajectories of SBD moving within D 3 R.
Trajectory and Free-Energy Potential Surface of SBD Moving along the Functional Molecular Channel within D 3 R. On the basis of the D 3 R−SBD complex optimized structure obtained by molecular dynamics simulation, we study six trajectories of SBD moving within D 3 R (Figure 4 ). The direction of the y+ axis is defined as the direction of SBD moving from the internal to external structure of D 3 R, and the y− axis refers to the movement of SBD from the internal to intracellular structure of D 3 R. The directions along the x+, x−, z+, and z− axes are the directions of SBD moving from D 3 R into the middle of the cell membrane. The most probable direction of SBD movement into the cellular membrane space can be determined by taking these four directions into consideration. 
In the y+ axis direction, Leu95 is selected as the reference group because it is near the SBD molecule in the reverse direction of motion. Because there is a relatively large space for the movement of water molecules and phospholipids in the system, such substances are not suitable to be used as the reference group. A maximum external force is set to 2000 kJ· mol −1 , which forces SBD to move along the y+ axis direction and permeate out of the cell. However, in the actual process, procedures are based on a system that will provide a suitable external force of less than 2000 kJ·mol −1 , prompting SBD to move and generate the trajectories of the coordinates. Figure 4 shows the structural figures of SBD's four-point systems on the trajectory, where o point is the starting point system. After the a and b point systems reach the c point trajectory system, the SBD molecule moves out of D 3 R through a molecular pathway.
Along the y+ axis direction, from the SBD trajectory coordinate file, 50 samples are selected to simulate rebalance of the sample system; these samples are listed in Table 2 . In the SBD trajectory file, data of 1001 points are to be preserved in different directions but are not necessary to use to simulate the umbrella samples. The 1001 trajectory points of the conformational data correspond to the length of 1000 ps molecular simulation, in which every 1 ps extracts a point of trajectory conformation data. Therefore, the sample number corresponds to the length of the trajectory simulation (ps unit). Using trajectory point system conformation data, centroid distances between the reference and motion groups can be calculated in different numbers of samples. According to the center distance of mass between SBD and the reference system, the selection of samples increases by about 0.05 nm. In different regions, because of the change of a given force, SBD displays rotational motion in addition to translational motion, resulting in a large change in the distance between the reference and moving groups, even if the centroid distance variations in adjacent umbrella samples are greater than 0.05 nm. During molecular motion, the reference frame of the system and centroid position of the moving group both change, restricting the actual distance in accordance with the 0.05 nm integer times; or in other words, the sample interval is not fully consistent with the 0.05 nm interval. For the selected 50 samples, the centroid distance between the motion and reference groups is respectively fixed; then, after 800 ps of molecular dynamic simulation, the SBD molecule and whole system are rebalanced, which are characterized using RMSD values. The results of this study are similar to those of previous studies, which also reported that the RMSD values of each sample system were maintained between ±0.02 and the ground value from 600 to 800 ps to show the achievement of a balanced sample system after 400 000 steps of molecular dynamics simulation (the data is not given in this article). Although the external force needs to form the trajectory caused the system to deviate slightly from the equilibrium, this deviation is not much different from that of the original system, meaning the system can be quickly rebalanced.
Although many samples are selected along the two trajectories and the molecular dynamics simulation is used to realize the rebalance, the simulations still belong to the biased results from the limited samplings. Therefore, the weighted histogram analysis method (WHAM) in Gromacs 4.5 program is adopted to convert the results of biased sampling into unbiased sampling. Then, the mean force potential (PMF) is calculated from the results of a series of umbrella samples to obtain the free-energy change diagram in Figure 4 .
The VMD program is used to demonstrate and analyze the trajectory of SBD. Using the distance between the sample and reference in the trajectory listed in Table 2 and considering the . In Figure 5 , Ser156 is selected as the reference system and the 44 samples are listed in Table 3 . Along the y− axis direction, SBD begins at starting point o, after a point (2.47 nm) and b point (3.06 nm) to reach c (3.54 nm) position, a Umbrella sampling chosen according to the distance of 0.05 nm between the sampling and reference groups from the track file recorded for SBD to move along the +y axis, n: the serial number recorded in the track file; D: the distance between the sampling and reference groups. The reference group is Leu95.
which basically leaves out of the internal structure of D 3 R. In Figure 5 , data show that the free-energy change required for SBD to leave out of the internal structure of D 3 R toward the intracellular position is 275.0 kJ·mol . One reason for the difference in free energy between the y+ and y− axes may be derived from the initial structural conformation of the D 3 R crystal protein. Because the outer end of the protein is combined with an antagonist, it creates an open protein structure. Another reason is that the molecular channel itself is not used to transport SBD molecules from the external environment into the cell. SBD itself needs to permeate through the cell membrane for playing a functional role, unlike dopamine through the synaptic transfer mainly through the dopamine transporter to complete transport through the cell membrane back to the inside cell, consistent with the results observed in some experiments.
26−28
Trajectory and Free Energy Potential Surface of SBD Moving along the Protective Molecular Channel within D 3 R. The trajectory and free-energy potential surface for SBD to move within D 3 R along the protective molecular channels are analyzed through the x+, x−, z+, and z− axes. From any one of these four directions, SBD molecules are likely to move from the internal structure of D 3 R and enter the cell membrane space. Figure 6 shows that SBD moves along the x+ axis into the space trajectory of the bilayer membrane, where the reference group is a Leu15 residue, and the selected 39 sample systems are listed in Table 4 . Combining the main and top views in Figure 6 , it can be seen that SBD starts from the start point of o along the x+ axis, after a point (1.88 nm) and b point (2.23 nm) to reach the c point (3.34 nm) position. From the slit of TM5−TM6 between the two transmembrane helices, SBD exits the internal structure of D 3 R. Along the x+ axis trajectory, the free-energy change of SBD movement in this process is determined to be 103.6 kJ·mol −1 . Table 5 lists 35 samples of SBD selected along the x− axis, where the reference group is a Val173 residue. Figure 7 displays the trajectory of SBD moving along the x− axis into the cell membrane. The main view and top views in Figure 7 both show that SBD starts from the start point of o along the x− axis direction, after a point (2.20 nm) and b point (2.78 nm) to reach the c point (3.21 nm) position. From the slit of TM1− TM7 between the two transmembrane helices, SBD leaves the D 3 R internal structure. Along the x− axis trajectory, the freeenergy change of the process is determined to be 242.1 kJ· mol −1 for SBD movement. Figure 8 shows that SBD moved along the z+ axis and entered the space trajectory of the bilayer membrane, in which the reference group is a Val251 residue and the 50 sample systems are listed in Table 6 . In the main and top views in Figure 8 , it can be seen that along the z+ axis, SBD started at the start point of o, after a point (1.14 nm) and b point (1.69 nm), to reach the c point (3.02 nm) position. From the slit of TM1−TM2 between the two transmembrane helices, SBD exits the D 3 R internal structure. Along the z+ axis trajectory, the free-energy change of the process is 459.7 kJ·mol −1 for SBD movement.
In Figure 9 , it can be seen that SBD move along the z− axis and entered the space trajectory of the bilayer membrane. For this axis, we select a Leu51 residue as the reference group and 45 samples, which are listed in Table 7 . Combining the main and top views in Figure 9 reveals that SBD begins at start point o along the z− axis direction, after a point (1.51 nm) and b point (1.97 nm), to reach the c point (3.16 nm) position. SBD then exits the internal structure of D 3 R from the slit of TM6− TM7 between the two transmembrane helices. Along the z− axis trajectory, the free-energy change of the process is 127.8 kJ· mol −1 for SBD movement. When SBD moves along the molecular channels within D 3 R, there is a certain degree of flexibility. It is also determined that within a certain range, the SBD molecules are always moving along the direction of less energy. When a transmembrane helix is in front of the SBD trajectory, the direction of SBD changes slightly and moves from the transmembrane helix to the gap to exit the cell. The trajectories along the y axis direction are farthest from the membrane's helix column gap and move toward the internal structure, unless subjected to the ring structure. By studying the four directions through x+, x−, z+, and z− axes, it should be possible to cover the most likely trajectories of SBD movement into the space within cell bilayer membrane. Therefore, for SBD movement along the protective molecular channels within D 3 R, the most probable trajectory of SBD is to leave the D 3 R internal structure between the TM5 and TM6 gap along the x+ axis, with a free-energy change of 103.6 kJ·mol −1 . When free dopamine molecules are located at cell synaptic clefts, they bind with different subtypes of dopamine receptors on the posterior membranes to initiate signal transmission and play the role of a neurotransmitter to control functions of movement, cognition, emotion, etc. During dopamine transport, dopamine molecules are easily combined with dopamine receptors along the functional molecular channels to act as neurotransmitters. The protective molecular channel provides a pathway for the dopamine molecules to remove themselves from the receptors after functioning as neurotransmitters. If there is no way for dopamine molecules to leave or if the free energy of the passage for dopamine becomes larger under certain conditions, dopamine molecules continually combine with their receptors and maintain as neurotransmitters. To prevent this from occurring, dopamine molecules need to move along a trajectory of less free energy. Our previous researches show that in the D 3 R structure, dopamine molecules are most likely to leave out of the D 3 R internal structure between the TM5 and TM6 gaps along the x+ axis, with a free-energy change of 65.8 kJ·mol
. 22 From this presented study, our results reveal that 103.6 kJ·mol −1 is the minimum value of freeenergy change for SBD to move along the x+ axis in the molecular channels and exit the internal structure of D 3 R from the gap of TM5−TM6 between two transmembrane helices. Before then, SBD first permeates into the inner cells and from the inner cells moves toward the active pocket along the reverse direction of y− axis, which is a spontaneous process with free energy of −275 kJ·mol −1 . In the structure, the space of the gap between TM5 and TM6 between is much wider than other gaps, which is viewed from the complex D 3 R protein with SBD. It has been demonstrated that it is easier for SBD to leave the D 3 R interior from the TM5 and TM6 gap along the protective molecular channel because the movement of SBD molecules along the functional channel requires a high free-energy change of 171.7 kJ·mol −1 . Considering that the exit path for SBD molecules out of D 3 R is the same as that for dopamine out of the D 3 R internal structure, SBD can "dredge" the protective molecular channel to increase the movement of dopamine out of the internal structure of D 3 R because SBD as a drug is of a high concentration relative to dopamine and has a selective movement along the protective molecular channel. This will also help to reduce the presence of dopamine within D 3 R and prevent dopamine molecules from excessively functioning as neurotransmitters, which contributes to the severity of schizophrenia symptoms.
Besides D 3 R, D 1 R, D 2 R, D 4 R, and D 5 R are all important systems for researches of schizophrenia and Parkinson's disease. D 3 R has strong homology with them and much common characteristics with them. At the first stage, because D 3 R is only one crystal protein structure of dopamine receptors, it is important for D 3 R used as a representative of them to study the free-energy changes for SBD moving along the molecular channels within D 3 R. In the crystal structure of D 3 R protein, for obtaining the stable protein crystal, the researchers used ETQ, an antagonist that is designed to stabilize the protein structure and facilitate protein crystallization. However, ETQ does not change the D 3 R structure very much; therefore, in any case, it is significant to study the free-energy changes for some molecules like dopamine moving along the molecular channels within D 3 R. In the next stage, we are studying the changes of free energy for SBD moving along the channels within the simulated D 1 R, D 2 R, D 4 R, and D 5 R protein structures to investigate the different characteristics for SBD moving in these channels. It is noted that our study idea is different from the traditional blocking method of representing antipsychotic activity. Our strategy to study schizophrenia is through dredging rather than blocking dopamine molecular channels. This result is characterized by SBD moving along the protective channel in the change of free energy being lower at 68.1 kJ·mol −1 than it is along the functional channel, and animal experiments have demonstrated its efficacy for the treatment of schizophrenia.
Similarly, we found three molecules preferentially moving through the functional channel because the free-energy barrier for them moving along the functional channel is lower at 60 kJ· mol −1 than it is for them moving along the protective channel, and animal experiments proved them to be effective for the treatment of Parkinson's disease.
In addition, the method of umbrella sampling is widely used to study changes of free energy for some molecules moving along the molecular passages, which is a typical method, by which a lot of work has been published. For the interaction energies between SBD and the active sites of D 3 R, we use quantum chemical calculation, an effective and useful method, by which many articles have also been published. More details in consistence with some corresponding experiments are described in the section of Methods and some references.
■ CONCLUSIONS
The free-energy change of 103.6 kJ·mol −1 shows that SBD molecules are more easily accessible along the protective channels within D 3 R. The access of SBD molecules is significant because this can help clear protective channels within the D 3 R structure and aid removal of dopamine molecules out of the D 3 R internal structure along the x+ axis, which prevents excessive neurotransmitter functioning of dopamine. Therefore, SBD has good potential as a drug for schizophrenia treatment and its pharmacology is closely related to its transmission dynamics along molecular channels and mechanism of transmission channels within dopamine receptors.
■ METHODS
Details of the D 3 R complex protein structure used in this study are based on results of our previous study. 20, 22 This D 3 R complex protein with DA was obtained using docking technology and molecular dynamics based on the crystal structure of mutated D 3 R (crystal number: 3PBL), 19 in which the original protein crystal structure for point mutations of amino acids had been mutated to the human amino acid sequence of D 3 R. In the crystal structure of the D 3 R protein, researchers introduced hydrophilic fragments between the TM3 and 4 to obtain the stable protein crystal. This fragment, which is not a sequence of the D 3 R protein itself, was removed from the structure because it is far from SBD and has little effect to SBD. The reason is that there are similar research systems between DA and SBD with D 3 R complex proteins; in our previous work, the binding free energy between DA molecule and D 3 R protein had been demonstrated to largely come from the residues within 0.6 nm of the D 3 R structure around the DA molecule. 19 Furthermore, it will hinder the membrane system construction. Besides, the original reverse-direction dimer form of D 3 R was obtained for stabilizing the crystal structure of membrane protein; 20 in fact, it is a single D 3 R protein structure. The research system of our study is for SBD moving within the channels of single D 3 R protein structure, so that it is a common preferable practice to use a single D 3 R protein structure.
The external condition of the biomembrane is important for the structural stability of membrane proteins. On the basis of our previous research, 20, 29 we used the phosphatidyl-choline molecule (1-palmitoyl-2-oleoylsn-glycero-3-phosphatidylcholine (POPC)) to construct a lipid biological bilayer membrane. At the end of POPC, there is an unsaturated CC double bond, which is preferentially used in the simulation of biological cell membrane over the saturated tail of phospholipid lipid molecules. 30−33 The POPC membrane−water model constructed using POPC phospholipid molecules has been previously reported in the literature, 30 whereas water molecules belong to SPC model molecules. 34, 35 SBD Molecule Docked with D 3 R. Considering the structure of the D 3 R−DA complex protein, SBD was docked onto the D 3 R protein using the Dock6 program. 36 The docking step is similar to that reported in the literature, 20 where MP2/6-3lG(d,p) was used to optimize the molecular structure of SBD, 37 whereas the DA molecule in the D 3 R−DA complex was used as a pointer molecule to obtain the D 3 R−SBD complex. The docking energy from the lowest energy conformation of SBD binding with D 3 R was determined to be −51.4 kJ·mol −1 . Molecular Dynamics Simulation of D 3 R−SBD Complex Protein Structure. Gromacs 4.5 program was utilized to perform molecular dynamics simulations of the D 3 R−SBD complex structure, and the results were analyzed using the VMD program.
38−41 SBD molecular force field parameters were written in Gromos96 force field format, and POPC molecular force field parameters were derived from previous literature 30 and then rewritten into Gromacs format data. At the beginning stage, energy optimization was used to eliminate the system's atomic coordinates from overlapping by choosing the steepest descent method for maximum 40 000 steps (Fmax < 100 kJ·mol
). Under 1 atm pressure and 310 K, this allowed water molecules to move following LINCS constraint algorithm using 200 ps-limited stimulation, whereas Berendsen coupling and temperature pressure coupling algorithms were used to set respective time constants to 0.1 and 5 ps. Periodic boundary conditions were applied in the system of 20 ns with each step of 2 fs for molecular dynamics simulations. For every 2000 steps (4 ps), a system file was recorded and output studies to calculate the various energies and analyze structural changes.
Trajectory and Free Energy Potential Surface of SBD Moving within D 3 R. On the basis of the D 3 R−SBD−POPC− H 2 O system, after molecular dynamic simulation, the trajectories for SBD moving within D 3 R were simulated using the method of umbrella samples from Gromacs 4.5 package 41 to calculate their free-energy potential surfaces. The principle to calculate the free-energy potential surface is based on the formula G = −RT ln K, where G is free energy and K is the equilibrium constant obtained via molecular simulation. Because similar simulations and calculations have been reported in related articles, 25 ,42−45 we do not introduce the details of simulation but simply provide important points. In this work, we used the system file obtained after the molecular dynamics simulation as the input file of the trajectory dynamics structure system and the topology file necessary for simulating the dynamics trajectories of SBD was the same as it in its simulation of the molecular dynamics structure. SBD was set as the moving group, the harmonic force constant was set to be 2000 kJ·mol −1 ·nm −1 , and the maximum speed of SBD moving was limited at 10 nm·ns −1 . Using the Nose−Hoover temperature coupling algorithm and Parrinello−Rahman pressure coupling algorithm, respective time constants were set to 0.2 and 1 ps at 310 K and 1 atm as the reference temperature and pressure, respectively. Along the positive and negative directions of X, Z, and Y, the simulation of trajectory dynamics was performed for 500 000 steps, with a step length of 2 fs. The appropriate residue contrary to the direction of movement was selected as the reference group.
According to the rule of 0.05 nm similarly reported in the literature, 24 the appropriate umbrella samples could be selected from the trajectory data file. During the formation of trajectory for SBD moving within D 3 R, the given force less than 2000 kJ· mol −1 prompted SBD to move and resulted in deformation of SBD molecules, whereas the total structures of SBD and D 3 R deviated from their equilibrium. Therefore, it was necessary to perform simulation of umbrella samples, i.e., under the condition of limited distance between the moving and reference groups, so that the SBD molecule and total system were rebalanced. The input files for simulation of the umbrella samples included the sample, topological, and pointer files with the parameter file. The parameters for the simulation of the umbrella samples were the same as those for the simulation of trajectories but with a speed set to 0 nm·ns −1 , indicating that the SBD molecule does not move along the trajectory; considering the distance between the two groups, rebalancing of the molecular dynamics simulations of the samples were determined using RMSD values, where simulations steps were set to 400 000 (800 ps) with a step length of 2 fs. Finally, from the biased sampling results of partial sampling into no statistical results and from a series of umbrella sample simulations, the weighted histogram analysis method from Gromacs 4.5 was used to extract the potential of mean force (PMF) with a calculation deviation of 10 −6 kJ·mol −1 (convergence calculation standard). 46 The PMF surface refers to the free-energy potential surface from which the free binding energy can be calculated. Another file output via the calculation of G_wham provides histogram data. If the overlap of histogram figures is not good, it will produce a zigzag type potential energy surface of PMF. On the contrary, our research results repeatedly show no occurrence of a zigzag type PMF potential energy surface, which means good overlap of the histogram figures. 22, 24, 25 This good overlap of the umbrella samples suggests that the WHAM method can be effectively used to calculate the reliability of ΔG values. 43 In addition, although there is no direct comparison of the experimental data, the reliability of free energy obtained by molecular dynamics simulations can be proved by comparing relevant experiments. As reported in the previous literature, the PMF method can be used to simulate the permeation of water molecules through the modeled POPC biological membranes, where the free-energy barrier is 16.8−29.4 kJ·mol whereas the experimental barrier is 16.8−37.8 kJ·mol −1 for water molecules passing through the cell membrane. 53−56 From these previously reported results, it is obvious that the simulation results are in good agreement with experimental results to demonstrate the reliability of the method used in this work. In another recent study, the same PMF method was utilized to calculate Na + −Cl − ion pair, Cl − ion, and Na + ion permeating through the POPC biological membrane and their free energy barriers were determined to be 115.0, 99.1, and 92.0 kJ·mol −1 , respectively, 57 whereas the barriers determined via the experiment were 98.7 ± 11.3 and 87.4 ± 1.7, respectively, for Cl − and Na + ions permeating through a phosphatidylserine membrane. 58 Considering that the latter-mentioned molecular simulation results showed good consistency with experimental results for Cl − and Na + ions, it is expected that both results in the similar biomembrane system should also be consistent in this work. 
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